Molecular biology of the Ah receptor and its role in carcinogenesis
Introduction
The aryl hydrocarbon receptor (AhR) was first identified in mouse liver by Poland et al. (1976) who showed specific binding to radiolabeled 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a highly toxic environmental toxicant that is a by-product of industrial processes and combustion of organic materials including municipal garbage. Subsequent studies with [3H]TCDD showed that the AhR was widely expressed in mammalian tissues, and it was hypothesized that initial binding to the AhR was linked to the broad spectrum of biochemical and toxic responses observed in laboratory animals and cells exposed to TCDD and other halogenated aromatic contaminants that bind the AhR (Poland and Knutson, 1982). For example, TCDD induces phase 1 and phase 2 drug metabolizing enzymes, modulates expression of many other genes/gene products and causes hepatoxic responses such as porphyria, immunotoxicity, developmental and reproductive toxicity, disruption of endocrine pathways, a wasting syndrome, chloracne, tumor promotion, and carcinogenesis. Interestingly, the toxic and genotoxic responses induced by TCDD are dependent on many factors including the age, sex, species and strain of experimental animal (Poland and Knutson, 1982). For example, dietary administration of TCDD for 2 years to Sprague–Dawley rats induces liver tumor formation in females, but not males, and this response appears to be linked to hormone expression (Kociba et al., 1978).
Section snippets
Mechanisms of AhR-mediated responses
The mechanism of AhR-mediated responses was initially investigated using CYP1A1 as a model (reviewed in Whitlock, 1993, Whitlock et al., 1996), and early studies showed that induction of CYP1A1 by TCDD was preceded by rapid formation of a 180–220 kD nuclear AhR complex. Subsequent studies showed that this complex was a heterodimer containing the AhR and AhR nuclear translocator (Arnt) protein, and both AhR and Arnt genes have been cloned and extensively characterized (Swanson and Bradfield, 1993
AhR-mediated carcinogenesis
The carcinogenic activity of TCDD and related compounds has recently been reviewed by a committee of scientists for the International Agency for Research on Cancer (IARC), and it was concluded by a majority of the committee that TCDD was a human carcinogen (Group 1) (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1997). The major support for this designation was the animal studies (multi-site carcinogen) and the increased overall cancer mortality from industrial cohorts
Inhibitory AhR-ERα crosstalk: rodent uterus and human breast/endometrial cancer cell lines
The AhR is expressed in the rodent uterus and results of several studies showed that TCDD and other AhR agonists inhibited 17β-estradiol (E2)-induced uterine wet weight increase, cell proliferation, progesterone receptor (PR) binding, peroxidase activity, epidermal growth factor (EGF) receptor binding, and expression of c-fos and EGF receptor mRNA levels. TCDD has been extensively used to investigate AhR-mediated inhibition of E2-induced responses in various breast cancer cell lines. Initial
Mechanisms of inhibitory AhR-ERα crosstalk
The mechanisms of inhibitory AhR-ER crosstalk have also been investigated and several possible pathways could contribute to these interactions. For example, AhR agonists induce CYP1A1/A2 and this results in rapid metabolism and cellular depletion of 17β-estradiol (E2) in cell culture but not in vivo. Various AhR agonists induce ER degradation and this is related to proteasome-dependent degradation pathways. Prolonged depletion of cellular ER could contribute to loss of E2-responsiveness for
Development and applications of selective AhR modulators (SAhRMs)
The initial report that TCDD inhibits age-dependent formation of mammary tumors in female Sprague–Dawley rats (Kociba et al., 1978) has been confirmed in other rodent models. TCDD also inhibits carcinogen-induced mammary tumor growth and formation in rats and mammary tumor growth in athymic mice bearing breast cancer cell xenografts. Epidemiology studies in women accidentally exposed to TCDD in Seveso, Italy, show lower incidence rates of breast and endometrial cancer (Bertazzi et al., 1993).
Summary
The AhR is a ligand-activated nuclear transcription factor that binds toxic halogenated aromatic compounds, such as TCDD but also an increasing number of chemoprotective phytochemicals, which exhibit both AhR agonist and antagonist activities. Assessment of the noncarcinogenic and carcinogenic risks associated with exposure to trace levels of TCDD and related compounds in the diet invariably ignores interactions with high level exposure to phytochemical AhR agonists/antagonists. The research
Acknowledgements
The financial assistance of the National Institutes of Health (CA64081 and ES09106), DAMD 17-99-1-93-96 Avax Technologies and the Texas Agricultural Experiment Station is gratefully acknowledged.
References (23)
- et al.
Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats
Toxicol. Appl. Pharmacol.
(1978) - et al.
Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists
Cancer Lett.
(1997) - et al.
Inhibition of carcinogen-induced rat mammary tumor growth and other estrogen-dependent responses by symmetrical dihalo-substituted analogs of diindolylmethane
Cancer Lett.
(2000) - et al.
Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase
J. Biol. Chem.
(1976) - et al.
17β-Estradiol-mediated growth inhibition of MDA-MB-468 cells stably transfected with the estrogen receptor: cell cycle effects
Mol. Cell. Endocrinol.
(1997) - et al.
Transcriptional activation of cathepsin D gene expression by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition.
Mol. Cell. Endocrinol.
(2001) - et al.
Crosstalk between estrogen receptor α and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteosomes
FEBs
(2000) - et al.
PCDDs, PCDFs, and PCBs in human milk from different parts of Norway and Lithuania
J. Toxicol. Environ. Health
(1995) - et al.
Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin
Epidemiology
(1993) - et al.
Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin
New Engl. J. Med.
(1991)
Identification of a motif within the 5′-regulatory region on pS2 which is responsible for Ap1 binding and TCDD-mediated suppression
Biochemistry
Cited by (279)
Unveiling the mechanistic role of the Aryl hydrocarbon receptor in environmentally induced Breast cancer
2023, Biochemical PharmacologyInterindividual variation contributes to differential PCB 126 induced gene expression in primary breast epithelial cells and tissues
2022, Ecotoxicology and Environmental SafetyOrganosulfur compounds (allyl sulfide, indoles)
2022, Antioxidants Effects in Health: The Bright and the Dark SideReproductive toxicity of polycyclic aromatic hydrocarbons
2022, Reproductive and Developmental ToxicologyAromatic hydrocarbon receptors in mitochondrial biogenesis and function
2021, MitochondrionToxicity and removal of parabens from water: A critical review
2021, Science of the Total Environment